NCT03249012 Quality of Life Related to Different Treatment Protocols for Post-thyroidectomy Hypoparathyroidism
| NCT ID | NCT03249012 |
| Status | Recruiting |
| Phase | — |
| Sponsor | CHU de Quebec-Universite Laval |
| Condition | Hypoparathyroidism Postprocedural |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2017-09-01 |
| Primary Completion | 2025-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2017-09-01 with a primary completion date of 2025-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to compare two different protocols commonly used in the management of post thyroidectomy hypoparathyroidism : PTH based calcium repletion and empiric repletion. The investigators aim to compare the quality of life associated with these two protocols in a randomized trial.
Eligibility Criteria
Inclusion Criteria: * Total thyroidectomy or completion hemithyroidectomy Exclusion Criteria: * Need for neck dissection * Unable to fill in questionnaires (intellectual deficit, severe psychiatric disorder, illiterate, does not speak French or English)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT03249012 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hypoparathyroidism Postprocedural. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03249012 currently recruiting?
Yes, NCT03249012 is actively recruiting participants. Contact the research team at jean-philippe.vezina@fmed.ulaval.ca for enrollment information.
Where is the NCT03249012 trial being conducted?
This trial is being conducted at Québec, Canada.
Who is sponsoring the NCT03249012 clinical trial?
NCT03249012 is sponsored by CHU de Quebec-Universite Laval. The trial plans to enroll 120 participants.